Pharmacokinetics of a new parenteral oligosaccharide antibiotic, SCH27899 (Ziracin), in healthy subjects

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 3, 2001, Pages 917-921

  Kozawa, O ^a   Uematsu, T ^a   Matsuno, H ^a   Niwa, M ^a   Kohno, K I ^a   Kawato, A ^a   Takahashi, K ^a   Nagashima, S ^a   Kanamaru, M ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EVERNIMICIN; OLIGOSACCHARIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG TOLERABILITY; DRUG URINE LEVEL; ERYTHEMA; HUMAN; PAIN; PRIORITY JOURNAL; VEIN THROMBOSIS;

ADULT; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; FEASIBILITY STUDIES; HUMANS; MALE; OLIGOSACCHARIDES;

EID: 0035115822     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.3.917-921.2001     Document Type: Article

References (16)

1. Transmission dynamics of epidemic methicillin-resistant Staphyococcus aureas and vancomycin-resistant enterococci in England and Wales
2. Comparison of inhibitor and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium
3. A roundtable discussion antibiotic resistance: Putting the lessons to work
4. Effects of hepatic function on vancomycin clinical pharmacology
5. Pharmacodynamic effects of antibiotics: Studies on morphology, initial killing, post antibiotic effect and effective growth time
6. Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: The role of streptogramins and other newer compounds
7. Antimicrobial activity and spectrum of SCH27899 (Ziracin) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control
8. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem
9. Pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring of glycopeptides
10. Antimicrobial activity of SCH27899 (Ziracin), a novel everninomicin derivative, tested against Streptococcus spp.: Disk diffusion/E-test method evaluations and quality control guidelines
11. Glycopeptide tolerance in Staphylococcus aurens
12. Everninomicin, a new oligosaccharide antibiotic: Its antimicrobial activity
13. The threat of vancomycin resistance
14. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients
15. Pharmacokinetics of vancomycin: Observation in 28 patients and dosage recommendation
16. Post antibiotic effect and clinical evaluation of teicoplanin